Van Elssen CHMJ - Search Results

1

NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?

Van Elssen CHMJ, Ciurea SO. Van Elssen CHMJ, et al. Int J Hematol. 2018 Feb;107(2):151-156. doi: 10.1007/s12185-017-2379-x. Epub 2017 Dec 1. Int J Hematol. 2018. PMID: 29196968 Review.

2

NK cell alloreactivity in acute myeloid leukemia in the post-transplant cyclophosphamide era.

Van Elssen CHMJ, Ciurea SO. Van Elssen CHMJ, et al. Am J Hematol. 2020 Dec;95(12):1590-1598. doi: 10.1002/ajh.25983. Epub 2020 Sep 28. Am J Hematol. 2020. PMID: 32857869 Free article. Review.

3

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors.

Van Elssen C, van Gorkom G, Voorter C, von dem Borne P, Meijer E, Wieten L, Bos G. Van Elssen C, et al. Ann Hematol. 2021 Jan;100(1):181-187. doi: 10.1007/s00277-020-04303-z. Epub 2020 Oct 28. Ann Hematol. 2021. PMID: 33112968 Free PMC article. Clinical Trial.

4

No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial.

van Gorkom GNY, Boerenkamp LS, Gijsbers BLMG, van Ojik HH, Wodzig WKWH, Wieten L, Van Elssen CHMJ, Bos GMJ. van Gorkom GNY, et al. Among authors: van elssen chmj. Nutrients. 2022 Nov 11;14(22):4784. doi: 10.3390/nu14224784. Nutrients. 2022. PMID: 36432471 Free PMC article. Clinical Trial.

5

In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus.

Meek B, Cloosen S, Borsotti C, Van Elssen CH, Vanderlocht J, Schnijderberg MC, van der Poel MW, Leewis B, Hesselink R, Manz MG, Katsura Y, Kawamoto H, Germeraad WT, Bos GM. Meek B, et al. Blood. 2010 Jan 14;115(2):261-4. doi: 10.1182/blood-2009-05-223990. Epub 2009 Oct 14. Blood. 2010. PMID: 19828700 Free article.

6

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice.

Frings PW, Van Elssen CH, Wieten L, Matos C, Hupperets PS, Schouten HC, Bos GM, van Gelder M. Frings PW, et al. Breast Cancer Res Treat. 2011 Dec;130(3):773-81. doi: 10.1007/s10549-011-1355-z. Epub 2011 Jan 28. Breast Cancer Res Treat. 2011. PMID: 21274621

7

Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.

Van Elssen CH, Vanderlocht J, Oth T, Senden-Gijsbers BL, Germeraad WT, Bos GM. Van Elssen CH, et al. Blood. 2011 Sep 1;118(9):2473-82. doi: 10.1182/blood-2010-09-307835. Epub 2011 Jun 29. Blood. 2011. PMID: 21715307 Free article.

8

Natural killer cells: the secret weapon in dendritic cell vaccination strategies.

Van Elssen CH, Oth T, Germeraad WT, Bos GM, Vanderlocht J. Van Elssen CH, et al. Clin Cancer Res. 2014 Mar 1;20(5):1095-103. doi: 10.1158/1078-0432.CCR-13-2302. Clin Cancer Res. 2014. PMID: 24590885 Free article. Review.

9

Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs.

Oth T, Van Elssen CH, Schnijderberg MC, Senden-Gijsbers BL, Germeraad WT, Bos GM, Vanderlocht J. Oth T, et al. J Interferon Cytokine Res. 2015 Sep;35(9):748-58. doi: 10.1089/jir.2015.0022. Epub 2015 Jul 2. J Interferon Cytokine Res. 2015. PMID: 26134473

10

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination.

Oth T, Vanderlocht J, Van Elssen CH, Bos GM, Germeraad WT. Oth T, et al. Mediators Inflamm. 2016;2016:5740373. doi: 10.1155/2016/5740373. Epub 2016 Feb 11. Mediators Inflamm. 2016. PMID: 26980946 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page